So-Young International Inc

Análisis de la acción So-Young International Inc (SY)

$2.090

+0.105 (+5.03%)Al cierre

Loading chart…
Máximo
2.095
Apertura
2.000
Precio medio ponderado por volumen
2.06
Volumen
117.81K
Capitalización
106.38M
Mínimo
2.000
Importe
242.89K
EV/EBITDA, TTM
-0.23

So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website.

www.soyoung.com

Análisis de IA of So-Young International Inc (SY)

Mantener

So-Young International Inc is not a good buy right now due to its current price of 1.99, which is significantly below its 52-week high of 4.75, and an RSI of 12.45 indicating it is oversold. While the company has shown revenue growth, with Q2 2026 revenue at 505.2 million CNY, a 33% year-over-year increase, it still faces significant net losses, with a net income of -22.7 million CNY in Q2 2026. The main risk is its negative earnings per share of -0.29, which reflects ongoing financial challenges despite some positive revenue trends.

Métricas de valoración

El PER previsto actual de So-Young International Inc (SY) es 16.29, frente a su media de 5 años de -8.30.

PER previsto

Valor razonable
Media 5A P/E
-8.30
P/E actual
16.29
Sobrevalorada
74.09
Infravalorada
-90.69

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
-21.74
EV/EBITDA actual
-0.23
Sobrevalorada
46.57
Infravalorada
-90.06

Precio/ventas previsto

Infravalorado
Media 5A P/S
0.63
P/S actual
0.07
Sobrevalorada
1.07
Infravalorada
0.19

Escenarios de precio de Alphio AI para SY

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%SY

$0.73

Precio del escenario

B

Base

Base · 50%SY

$0.70

Precio del escenario

B

Bajista

Bajista · 25%SY

$0.56

Precio del escenario

Ballenas con SY en cartera

O

Oasis Management Company Ltd.

+ Con en carteraSY

-12.75%

Rentabilidad a 3 meses

Cronología de eventos

2026-08-04 (ET)

17:30:00

So-Young International Appoints Nan Shen as CFO

2025-07-03 (ET)

05:57:46

So-Young regains Nasdaq compliance

2025-05-30 (ET)

06:13:54

So-Young plans to implement ADS ratio change

2025-02-27 (ET)

05:51:36

So-Young to transfer listing to Nasdaq Capital

2024-11-20 (ET)

04:29:12

So-Young sees Q4 revenue RMB 350M-RMB 370M

Noticias

Preguntas frecuentes sobre SY, respondidas por Alphio AI

So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website. It operates in the Consumer Cyclicals sector (COMPUTER PROCESSING AND DATA PREPARATION AND PROCE industry).

So-Young International Inc is not a good buy right now due to its current price of 1.99, which is significantly below its 52-week high of 4.75, and an RSI of 12.45 indicating it is oversold. While the company has shown revenue growth, with Q2 2026 revenue at 505.2 million CNY, a 33% year-over-year increase, it still faces significant net losses, with a net income of -22.7 million CNY in Q2 2026. The main risk is its negative earnings per share of -0.29, which reflects ongoing financial challenges despite some positive revenue trends.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar